Lyon, France-based Medicrea reported quarter one 2017 sales of $7.43 million.
Here are three takeaways:
1. Medicrea saw a 38 percent increase in U.S. cases leveraging the UNiD Rods.
2. In Q1, the company moved all manufacturing operations from its La Rochelle site to a new facility in Rillieux-la-Pape.
3. The company will highlight its UNiD Adaptive Spine Intelligence and patient-specific implants at the International Society for the Advancement of Spine Surgery annual meeting, in Boca Raton, Fla., from April 12 to 14.